| Date |
Title |
Category |
|
| 30/12/2005 | Novartis up on Femara study results and approval | Company financials | Read More |
| 16/12/2005 | MSD in $1bn cost cutting | Company financials | Read More |
| 16/12/2005 | Serano pleads guilty to Aids investigation | Company financials | Read More |
| 15/12/2005 | Lundbeck buys back shares | Company financials | Read More |
| 15/12/2005 | GlaxoSmithKline could pay Vertex $405m | Company financials | Read More |
| 14/12/2005 | Bristol-Myers Squibb plans restructuring | Company financials | Read More |
| 13/12/2005 | Eli Lilly ups growth prediction | Company financials | Read More |
| 13/12/2005 | UCB Pharmaceuticals confirms positive outlook | Company financials | Read More |
| 13/12/2005 | MSD trial brings no results | Company financials | Read More |
| 13/12/2005 | Schwarz Pharma establishes 275m euro credit facility | Company financials | Read More |
| 12/12/2005 | ?275m credit facility | Company financials | Read More |
| 12/12/2005 | GlaxoSmithKline faces Seroxat legal action | Company financials | Read More |
| 09/12/2005 | AstraZeneca buys rights to septic drug form UK's Protherics | Company financials | Read More |
| 08/12/2005 | Pharma marketing budgets shown to be similar despite product size | Company financials | Read More |
| 06/12/2005 | Pfizer tops contacts to managed care executives | Company financials | Read More |
